Rs. King et al., PHARMACEUTICAL SERVICES AND INPATIENT DRUG COSTS IN BONE-MARROW TRANSPLANTATION, American journal of hospital pharmacy, 51(10), 1994, pp. 1339-1342
A survey of U.S. bone marrow transplantation (BMT) programs was conduc
ted to determine the role of pharmaceutical services in those programs
and the pharmacy department resources allocated to support them. Surv
eys were sent to 92 U.S. BMT programs to solicit the following informa
tion: characteristics of the institution and the BMT program, extent o
f pharmacist involvement in the BMT program, and pharmacy resource all
ocation to the program. Fifty-five responses were received (60% respon
se rate). BMT pharmacists were employed by 53 of these institutions (a
total of 66 pharma- cists). BMT pharmacists at 49 of the 53 instituti
ons (92%) received their salary from the department of pharmacy. Commo
n BMT pharmacist responsibilities included managing adverse effects (1
00% of respondents), adjusting medication doses (96%), providing drug
information (94%), participating in BMT team rounds (87%), maintaining
medication profiles (85%), and developing medication protocols (81%).
Inpatient BMT-related drug costs (reported by 37 respondents) average
d 12% of the pharmacy's annual inpatient drug budget. One or more phar
macists were members of the BMT team at 46 of 53 institutions. BMT-rel
ated drug costs accounted for 12% of the total inpatient drug budget a
t the 37 institutions reporting cost data.